Skip to main navigation
Skip to search
Skip to main content
The Rotterdam Eye Hospital and Rotterdam Ophthalmic Institute Home
English
Nederlands
Search content at The Rotterdam Eye Hospital and Rotterdam Ophthalmic Institute
Home
Research output
Profiles
Activities
Press/Media
Research units
Eyelid Merkel cell carcinoma in a patient treated with golimumab
H Hanafi
, R M Verdijk
,
D Paridaens
Orbita and oculoplastic surgery
Research output
:
Contribution to journal
›
Letter
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Eyelid Merkel cell carcinoma in a patient treated with golimumab'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Eyelid
100%
Golimumab
100%
Merkel Cell Carcinoma
100%
Rheumatoid Arthritis
50%
Tumour Necrosis Factor Inhibitor (TNFi)
50%
Injection Therapy
25%
Older Women
25%
Upper Eyelid
25%
Biopsy-proven
25%
Inhibitor Injection
25%
Eyelid Mass
25%
Eyelid Tumor
25%
Differential Diagnosis
25%
Anti-tumor Necrosis Factor Therapy
25%
Medicine and Dentistry
Eyelid
100%
Golimumab
100%
Merkel Cell Carcinoma
100%
Biopsy
50%
Rheumatoid Arthritis
50%
TNF Inhibitor
50%
Upper Eyelid
25%
Differential Diagnosis
25%
Tumor Necrosis Factor
25%
Eyelid Tumor
25%